Skip to main content
. 2019 Mar 8;9:3979. doi: 10.1038/s41598-019-40482-0

Table 2.

Association between rs4828038 TNMD and anthropometric, biochemical, and inflammation characteristics (mean (SD)) in children.

Phenotype Genotypes Β (95%CI) P FDR adjusted P ΒBMI (95%CI) P BMI FDR adjusted P BMI
T/T nT/T T/C nT/C C/C nC/C
Waist circumference (cm)
Females 75.68 (15.11) 124 77.13 (16.68) 168 77.15 (15.13) 168 −0.42 (−2.05, 1.04) 0.611a 0.694 −1.22 (−2.06, −0.38) 0.005a 0.024
Males 80.9 (17.4) 157 NA 0 77.04 (17.3) 220 3.76 (0.55, 6.98) 0.022a 0.088 −0.1 (−1.54, 1.35) 0.897a 0.962
Waist to Height Ratio
Females 0.526 (0.09) 109 0.54 (0.10) 151 0.53 (0.09) 142 −0.002 (−0.01, 0.009) 0.701a 0.876 −0.01 (−0.01, 0.001) 0.030a 0.172
Males 0.54 (0.10) 130 NA 0 0.53 (0.10) 194 0.015 (−0.007, 0.04) 0.183a 0.735 −0.002 (−0.01, 0.01) 0.678a 0.753
Systolic BP (mmHg)
Females 104.8 (14.43) 108 106.9 (12.73) 148 104.9 (13.81) 136 0.006 (−1.65, 1.66) 0.995b 0.995 −0.46 (−1.95, 1.03) 0.542b 0.995
Males 107.7 (15.06) 131 NA 0 105.9 (16.31) 193 1.01 (−2.15, 4.17) 0.531b 0.995 0.07 (−2.91, 3.05) 0.963b 0.995
Diastolic BP (mm Hg)
Females 62.82 (11.99) 108 65.17 (10.46) 148 65.46 (10.77) 136 −1.3 (−2.68. 0.09) 0.067b 0.332 −1.60 (−2.91, −0.30) 0.016b 0.102
Males 65.55 (11.31) 131 NA 0 63.82 (10.49) 193 1.53 (−0.82, 3.88) 0.204b 0.446 0.96 (−1.32, 3.23) 0.410b 0.708
Glucose (mg/dl)
Females 84.7 (7.93) 132 83.64 (6.89) 170 84.37 (7.02) 172 0.16 (−0.66, 0.97) 0.707a 0.980 0.18 (−0.62, 0.99) 0.658a 0.906
Males 85.9 (8.45) 171 NA 0 83.71 (8.43) 235 2.22 (0.57, 3.87) 0.009a 0.049 2.21 (0.55, 3.88) 0.009a 0.054
Insulin (mU/dl)
Females 12.85 (10.15) 131 13.5 (9.54) 164 11.63 (7.10) 167 0.81 (−0.14, 1.76) 0.094a 0.196 0.72 (−0.15, 1.59) 0.104a 0.443
Males 10.86 (7.67) 166 NA 0 9.50 (7.56) 224 1.39 (−0.02, 2.79) 0.053a 0.196 0.74 (−0.55, 2.02) 0.261a 0.443
HOMA-IR
Females 2.76 (2.36) 131 2.82 (2.04) 163 2.44 (1.55) 166 0.2 (−0.01, 0.41) 0.064a 0.186 0.18 (−0.02, 0.38) 0.075a 0.386
Males 2.34 (1.79) 165 NA 0 2.02 (1.72) 224 0.33 (0.009, 0.66) 0.044a 0.186 0.19 (−0.11, 0.50) 0.207a 0.386
QUICKI
Females 0.35 (0.05) 131 0.34 (0.04) 163 0.35 (0.04) 165 0.0001 (−0.004, 0.004) 0.953a 0.952 0.0005 (−0.003, 0.004) 0.787a 0.810
Males 0.35 (0.04) 165 NA 0 0.37 (0.05) 224 −0.01 (−0.02, −0.003) 0.006a 0.038 −0.008 (−0.02, −0.0004) 0.039a 0.232
TAG (mg/dl)
Females 72.57 (36.18) 132 71.58 (32.59) 170 67.1 (27.12) 172 2.86 (−0.74, 6.46) 0.120a 0.615 2.63 (−0.87, 6.13) 0.142a 0.878
Males 65.53 (35.37) 172 NA 0 64.32 (35.51) 234 1.35 (−5.59, 8.29) 0.703a 0.915 −1.00 (−7.74, 5.73) 0.771a 0.905
HDL-c (mg/dl)
Females 52.32 (14.03) 130 51.95 (13.77) 168 53.39 (13.69) 171 −0.6 (−2.17, 0.96) 0.451a 0.683 −0.35 (−1.76, 1.06) 0.625a 0.960
Males 55.25 (15.1) 169 NA 0 56.69 (16.53) 231 −1.53 (−4.67, 1.60) 0.338a 0.683 0.20 (−2.64, 3.04) 0.892a 0.960
IL-6 (ng/l)
Females 3.86 (7.22) 106 2.78 (4.51) 152 2.21 (3.83) 151 0.80 (0.17, 1.44) 0.014a 0.047 0.75 (0.12, 1.38) 0.021a 0.073
Males 3.25 (6.29) 142 NA 0 3.53 (5.80) 205 −0.30 (−1.59, 0.98) 0.642a 0.818 −0.38 (−1.68, 0.92) 0.568a 0.727

BMI, body mass index; BP, blood pressure; HOMA-IR, homeostasis model assessment for insulin resistance; QUICKI, quantitative insulin sensitivity check index; TAG, triglycerides; HDL-C, high-density lipoprotein cholesterol; IL, interleukin; MAF, minor allele frequency; βBMI, Beta obtained under an additive model adjusted for BMI; P-valueBMI, P (P value) obtained under an additive model adjusted for BMI; CI, confidence interval; NA, not applicable. Linear regression analyses stratified by sex were performed under an additive model assuming TNMD locus escapes from the X-chromosome inactivation process. That is, while the female genotypes were coded 0, 1, or 2 according to 0, 1, or 2 TNMD SNP alleles, the genotypes for males were coded 0 or 1 according to 0 or 1 alleles. aAdjusted for age. bAdjusted for age and height.